Drugs / pegylated interpheron alpha-2a
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01602939 | May 2012 → Feb 2017 | systemic mastocytosis | Hospital Virgen de la Salud | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pegylated interpheron alpha-2a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01602939 ↗ |
| Route | Subcutaneous | “Pegylated Interpheron alpha-2a (1 mcgr/Kg) s.c weekly for a total of 6 months.” NCT01602939 ↗ |